|
. κ з 1. 9 2. з 12
. κ 1. κ 21 2. κ 22
. κ » 1. 35 2. Type 2 CRS 36 3. Non-type 2 CRS 41 4. Fibrin ħ(deposition) 45
. κ ġ 4-1. 52 1. ܱⰣ 汸 52 2. Ⱓ 汸 56 3. 61 4. ֻ 62
4-2. ̵ 67 1. ҿ ̵ 68 2. 汸 ̵ 69 3. ̵ ô(corticosteroid irrigation) 71 4. ̵ öƮ(corticosteroid-eluting implants) 71
4-3. Ÿ, , Ʈ 75 1. Ÿ 76 2. () 77 3. Ʈ 78
4-4. Ŀ ڼô 82 1. 83 2. Ŀ ô 83 3. Ÿ ô 85 4. ô غ 88 5. ҵ 89
4-5. 96 1. ʿ伺 97 2. ʴ κ 98 (uncontrolled severe CRSwNP) 3. ۿ 㰡(approval) Ȳ 98 4. ȿ 101 5. Ư ǰ(recommendation level) 102 6. 107 7. Ȳ 108 8. ̷ 110
. κ ġ 5-1. κ ð 118 1. 119 2. ˻ ġ 뼺 120 3. ġ 121 4. 122 5. ñ 122 6. ð κ 123 7. κ 130
5-2. 137 1. 138 2. ǥ 140 3. 141 4. 141 5. 142 6. 145 7. 147
5-3. / ġ 151 1. ð κ 152 2. κ óġ 154
. ġ κ ȯ ġ 1. ġ κ 171 2. ġ κ ġ ħ 꼺 172 3. 173 4. ġ 177
2005 7 ù ߰ κ ġ ̵Ρ ƴ϶ κ ٷ پ о Ƿ ε鿡Ե ħ ȰǾ մϴ. ù ̵ ۵ ð Ͽ, κ » ġ ־ ȸ ̵ ʿ伺 ϰ κ Ʈ ߰ϰ Ǿϴ. κ ȯ ϳ ȸ δ ϰ ֽϴ. ֱ κ ǥ зϰ , ̿ ȯ ġῡ Եǰ ֽ . κ ƴ϶ Ÿ ƽþ ٸ » Ư¡ , κ Ư ȭϰ ֽϴ. ̹ κ Ʈ κ з, , ġ, õ Ļ ƴ϶ ġ κ ġ ϰ 忡 ֵ ˱ , Ͽϴ. Ѻȸ ȸ е鲲 о߿ پ ֽ ϱ ּ Խ ϴ. ̹ Ʈ ȸ κ ȸ ߽ Ǿ 忡 ʿ ϴ ֽ ġ ħ ȸԵ鲲 ϰ ϴ Դϴ. ̹ κ Ʈ , ǿ ֽ Ե 帮, ̹ Ʈ ȸ е ῡ ֱ⸦ ٶϴ.
|